RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
5.24
+0.65 (14.16%)
Nov 4, 2026, 1:27 PM EST - Market open
RxSight Market Cap
RxSight has a market cap or net worth of $217.95 million as of November 4, 2026. It is the 20,749th most valuable company in the world and the 3,602nd biggest in the United States. Its market cap has decreased by 39.40% in one year.
Market Cap
217.95M
Enterprise Value
-26.41M
1-Year Change
-39.40%
Global Rank
Country Rank
#3,602 United States
Category
ChartMarket Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $217.95M, a decrease of -48.64%. That is a compound annual growth rate of -11.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 199.65M | -53.40% |
| Dec 31, 2025 | 428.44M | -69.08% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Treace Medical Concepts | 288.10M |
| InfuSystem Holdings | 280.23M |
| Profound Medical | 240.36M |
| Standard BioTools | 239.47M |
| TriSalus Life Sciences | 227.83M |
| Electromed | 224.08M |
| Inogen | 182.05M |
| Neuronetics | 171.44M |